CMyc All NHL Test
Introduction
The CMyc All NHL test is a crucial diagnostic tool used primarily in the field of oncology. This test is designed to detect abnormalities in the CMyc gene, which can play a significant role in the development of Non-Hodgkin Lymphoma (NHL) and other malignancies. Understanding these genetic markers is essential for patient management and treatment planning.
What the Test Measures
This test specifically measures the presence and status of the CMyc gene, which is known to be involved in cell cycle regulation and proliferation. Abnormalities in this gene can indicate a higher risk for certain types of cancers, particularly NHL.
Who Should Consider This Test
Individuals who may benefit from the CMyc All NHL test include:
- Patients exhibiting symptoms related to lymphoma, such as swollen lymph nodes, unexplained weight loss, fever, or night sweats.
- Individuals with a family history of lymphoma or other cancers.
- Patients who have undergone previous cancer treatments and are experiencing new symptoms.
Benefits of Taking the Test
Taking the CMyc All NHL test provides several benefits:
- Early detection of potential genetic risks associated with Non-Hodgkin Lymphoma.
- Guidance in tailoring treatment plans based on genetic findings.
- Improved monitoring of patients with a history of lymphoma.
Understanding Your Results
Results from the CMyc All NHL test will indicate whether any genetic abnormalities are present. A healthcare provider will interpret these results, discussing their implications for treatment and management. It is essential to follow up with your doctor to understand the next steps based on your results.
Test Information and Pricing
| Test Name | CMyc All NHL |
|---|---|
| Discount Price | 105,000 NGN |
| Regular Price | 140,000 NGN |
Book the Test
To schedule your CMyc All NHL test, please contact us at +2348110567037. Ensure you have a doctor’s prescription before booking, as this test is not applicable for surgery and pregnancy cases or for individuals planning to travel abroad.
Turnaround time for results is typically 3-4 days, and the sample type required is bone marrow or peripheral blood, collected in a Sodium Heparin Vacutainer (2ml).
